Bogumila Osekowska

Szczecin, ZP 70111, Poland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Outcome of Second Primary Malignancies Developing in Multiple Myeloma Patients.

Outcome of Second Primary Malignancies Developing in Multiple Myeloma Patients.

Journal: Cancers
Published: June 11, 2023

Safety of Cryopreserved Stem Cell Infusion through a Peripherally Inserted Central Venous Catheter.

Safety of Cryopreserved Stem Cell Infusion through a Peripherally Inserted Central Venous Catheter.

Journal: Cancers
Published: January 22, 2023

Secondary Hemophagocytic Syndrome in a Patient with Plasma Cell Myeloma and CNS Involvement Treated with Lenalidomide.

Secondary Hemophagocytic Syndrome in a Patient with Plasma Cell Myeloma and CNS Involvement Treated with Lenalidomide.

Journal: Medicina (Kaunas, Lithuania)
Published: September 02, 2022

Adjuvant Lineage-Negative Cell Therapy as a Potential Silencer of the Complement-Mediated Immune System in ALS Patients.

Adjuvant Lineage-Negative Cell Therapy as a Potential Silencer of the Complement-Mediated Immune System in ALS Patients.

Journal: Journal of clinical medicine
Published: October 05, 2021

The Potential Role of Proinflammatory Cytokines and Complement Components in the Development of Drug-Induced Neuropathy in Patients with Multiple Myeloma.

The Potential Role of Proinflammatory Cytokines and Complement Components in the Development of Drug-Induced Neuropathy in Patients with Multiple Myeloma.

Journal: Journal of clinical medicine
Published: September 07, 2021

COVID-19 during Early Phase of Autologous Stem Cell Transplantation.

COVID-19 during Early Phase of Autologous Stem Cell Transplantation.

Journal: Medicina (Kaunas, Lithuania)
Published: June 24, 2021

microRNAs as the biomarkers of chemotherapy-induced peripheral neuropathy in patients with multiple myeloma.

microRNAs as the biomarkers of chemotherapy-induced peripheral neuropathy in patients with multiple myeloma.

Journal: Leukemia & lymphoma
Published: June 07, 2021

Long-Term Effects of Adjuvant Intravitreal Treatment with Autologous Bone Marrow-Derived Lineage-Negative Cells in Retinitis Pigmentosa.

Long-Term Effects of Adjuvant Intravitreal Treatment with Autologous Bone Marrow-Derived Lineage-Negative Cells in Retinitis Pigmentosa.

Journal: Stem cells international
Published: December 14, 2020

Humoral Influence of Repeated Lineage-Negative Stem/Progenitor Cell Administration on Articulatory Functions in ALS Patients.

Humoral Influence of Repeated Lineage-Negative Stem/Progenitor Cell Administration on Articulatory Functions in ALS Patients.

Journal: Stem cells international
Published: August 24, 2020

Repeated Application of Autologous Bone Marrow-Derived Lineage-Negative Stem/Progenitor Cells-Focus on Immunological Pathways in Patients with ALS.

Repeated Application of Autologous Bone Marrow-Derived Lineage-Negative Stem/Progenitor Cells-Focus on Immunological Pathways in Patients with ALS.

Journal: Cells
Published: June 12, 2020

Local and Systemic Humoral Response to Autologous Lineage-Negative Cells Intrathecal Administration in ALS Patients.

Local and Systemic Humoral Response to Autologous Lineage-Negative Cells Intrathecal Administration in ALS Patients.

Journal: International journal of molecular sciences
Published: December 31, 2019

Influence of Lineage-Negative Stem Cell Therapy on Articulatory Functions in ALS Patients.

Influence of Lineage-Negative Stem Cell Therapy on Articulatory Functions in ALS Patients.

Journal: Stem cells international
Published: February 26, 2019
Showing 1-12 of 15

Last Updated: 09/26/2026